Literature DB >> 8377524

Comparison of the Gompertz and Weibull functions as descriptors for human mortality distributions and their intersections.

D A Juckett1, B Rosenberg.   

Abstract

The Gompertz and Weibull functions are compared with respect to goodness-of-fit to human mortality distributions; ability to describe mortality curve intersections; and, parameter interpretation. The Gompertz function is shown to be a better descriptor for 'all-causes' of deaths and combined disease categories while the Weibull function is shown to be a better descriptor of purer, single causes-of-death. A modified form of the Weibull function maps directly to the inherent degrees of freedom of human mortality distributions while the Gompertz function does not. Intersections in the old-age tails of mortality are explored in the context of both functions and, in particular, the relationship between distribution intersections, and the Gompertz ln[R0] versus alpha regression is examined. Evidence is also presented that mortality intersections are fundamental to the survivorship form and not the rate (hazard) form. Finally, comparisons are made to the parameter estimates in recent longitudinal Gompertzian analyses and the probable errors in those analyses are discussed.

Entities:  

Mesh:

Year:  1993        PMID: 8377524     DOI: 10.1016/0047-6374(93)90068-3

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  16 in total

1.  Longevity and correlated frailty in multigenerational families.

Authors:  Gilda Garibotti; Ken R Smith; Richard A Kerber; Kenneth M Boucher
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2006-12       Impact factor: 6.053

2.  Changes in Physical Functioning as Short-Term Predictors of Mortality.

Authors:  Theresa Andrasfay
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2020-02-14       Impact factor: 4.077

3.  Differing types of medical prevention appeal to different individuals.

Authors:  Nicolas Bouckaert; Erik Schokkaert
Journal:  Eur J Health Econ       Date:  2015-07-19

4.  Predicting clonal self-renewal and extinction of hematopoietic stem cells.

Authors:  Hans B Sieburg; Betsy D Rezner; Christa E Muller-Sieburg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-28       Impact factor: 11.205

5.  High-quality life extension by the enzyme peptide methionine sulfoxide reductase.

Authors:  Hongyu Ruan; Xiang Dong Tang; Mai-Lei Chen; Mei-Ling A Joiner; Guangrong Sun; Nathan Brot; Herbert Weissbach; Stefan H Heinemann; Linda Iverson; Chun-Fang Wu; Toshinori Hoshi; M-L Chen; M A Joiner; Stephen H Heinemann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

6.  A mathematical-adapted model to analyze the characteristics for the mortality of COVID-19.

Authors:  Baobing Hao; Chengyou Liu; Yuhe Wang; Ninjun Zhu; Yong Ding; Jing Wu; Yu Wang; Fang Sun; Lixun Chen
Journal:  Sci Rep       Date:  2022-03-31       Impact factor: 4.379

7.  Age differential mortality in Spain, 1900-1991.

Authors:  J Llorca; M D Prieto; C F Alvarez; M Delgado-Rodriguez
Journal:  J Epidemiol Community Health       Date:  1998-04       Impact factor: 3.710

8.  Models for the red blood cell lifespan.

Authors:  Rajiv P Shrestha; Joseph Horowitz; Christopher V Hollot; Michael J Germain; John A Widness; Donald M Mock; Peter Veng-Pedersen; Yossi Chait
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-04-02       Impact factor: 2.745

Review 9.  Obesity and mortality: are the risks declining? Evidence from multiple prospective studies in the United States.

Authors:  T Mehta; K R Fontaine; S W Keith; S S Bangalore; G de los Campos; A Bartolucci; N M Pajewski; D B Allison
Journal:  Obes Rev       Date:  2014-06-09       Impact factor: 9.213

10.  Turning the analysis of obesity-mortality associations upside down: modeling years of life lost through conditional distributions.

Authors:  Henry T Robertson; Gustavo de los Campos; David B Allison
Journal:  Obesity (Silver Spring)       Date:  2013-02       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.